Seres Therapeutics shares are trading lower after the company annoucned it signed an agreement with Nestle for the sale of its VOWST business.
Portfolio Pulse from Benzinga Newsdesk
Seres Therapeutics shares are trading lower after the company announced it signed an agreement with Nestle for the sale of its VOWST business.
August 06, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Seres Therapeutics shares are trading lower following the announcement of an agreement with Nestle to sell its VOWST business.
The sale of the VOWST business to Nestle is likely seen as a negative by investors, leading to a drop in Seres Therapeutics' share price. This could be due to concerns about the company's future revenue streams or strategic direction post-sale.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100